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INTRODUCTION
Cellular injury can trigger a variety of responses, such as
adaptation, repair, proliferation and cell death. Apoptosis is
a programmed cell death that has been implicated in the
regulation of tissue homeostasis, and the pathophysiologic
process of neurologic disorders, such as Alzheimer’s disease,
Parkinson’s disease, Huntington’ disease, amyotrophic later-
al sclerosis, and ischemic insults (1, 2). 
It is generally believed that the mechanism of apoptotic
cell death is different from necrosis. By electron microscopic
analysis, apoptotic cell death demonstrates specific morpho-
logical changes including cell shrinkage, chromatin conden-
sation, DNA fragmentation, membrane blebbing, apoptotic
body formation, while necrosis is consistent with cell swelling
and destruction of cell morphology with the release of intra-
cellular organelles. During the early phase of apoptosis, phos-
phatidylserine (PS), which is normally almost totally confined
to the inner layer of phospholipid plasma membrane is moved
to the outer leaflet of the plasma membrane by the decreased
ATP-dependent translocase (flippase) activity and the increased
calcium-dependent scramblase activity while maintaining the
plasma membrane integrity (2-4). Fluorescein isothiocyanate
(FITC)-conjugated annexin-V, which is a Ca2+ dependent phos-
pholipid binding protein, is used as a reliable marker for PS
exposure (3, 5, 6). During the late phase of apoptosis, a shift
from tightly to loosely packing of the plasma membrane phos-
pholipids with PS externalization allows propidium iodide
(PI) penetration into the cell and binding with DNA. Dou-
ble staining of cells with FITC-annexin-V and PI in associa-
tion with flow cytometry has been proven to be a valuable
method to discriminate between early and late phase of apop-
tosis. Changes in morphology of the apoptotic cell can also
be monitored by flow cytometry as a change in light-scatter-
ing properties, forward scattering (FSC) and side scattering
(SSC) (5, 7).
Central nervous system (CNS) neurons are extremely sensi-
tive to metabolic changes and physio-chemical injuries. Resto-
ration of neuronal viability after apoptotic or necrotic cell death
has been suggested to be impossible, therefore, it is hoped that
more focused therapies to prevent apoptotic cell death could
be developed. Many clinicians are reluctant to use ketamine
in head injury patients in the clinical setting due to an increase
in the cerebral metabolic rate, cerebral blood flow, and intra-
cranial pressure. However, the protective effect of ketamine
in the amelioration of ischemic insults of CNS has been report-
ed in several animal and cellular experiments. Ketamine was
reported to suppress excessive excitatory amino acid release,
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Effect of Ketamine on Apoptosis by Energy Deprivation in Astroglioma
Cells using Flow Cytometry System
Apoptosis is a programmed, physiologic mode of cell death that plays an important
role in tissue homeostasis. As for the central nervous system, ischemic insults can
induce pathophysiologic cascade of apoptosis in neurophils. Impairment of astroc-
tye functions during brain ischemia can critically influence neuron survival by neuron-
glia interactions. We aimed to elucidate the protective effect of ketamine on apop-
tosis by energy deprivation in astrocytes. Ischemic insults was induced with iodoac-
etate/carbonylcyanide m-chlorophenylhydrazone (IAA/CCCP) 1.5 mM/20  M or 150
M/2  M for 1 hr in the HTB-15 and CRL-1690 astrocytoma cells. Then these cells
were reperfused with normal media or ketamine (0.1 mM) containing media for 1 hr
or 24 hr. FITC-annexin-V staining and propidium iodide binding were determined by
using flow cytometry. Cell size and granularity were measured by forward and side
light scattering properties of flow cytometry system, respectively. An addition of keta-
mine during reperfusion increased the proportion of viable cells. Ketamine alleviated
cell shrinkage and increased granularity during the early period, and ameliorated
cell swelling during the late reperfusion period. Ketamine may have a valuable effect
on amelioration of early and late apoptosis in the astrocytoma cells, even though
the exact mechanism remains to be verified.
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attenuate the development of focal brain edema, and amelio-
rate neurological dysfunction after neuronal injury in animal
experiments (8-12). 
Recent studies have revealed that glial cells are regarded
to play many important roles, such as regulating extracellu-
lar concentrations of ions, metabolites, and neurotransmitters,
and participated in synaptic functions with neurons in CNS.
Therefore, damage of the most abundant glial cells, astrocytes,
can bring about crucial influence on the neuronal survival
(13-15). It is now well known that signals between astroglial
cells and neurons go back and forth to modulate synaptic
activity (16-18).
Here, under in vitro conditions, we investigated the effect
of ketamine and reperfusion on the apoptosis of the astrocy-
toma cells following energy depletion with glycolysis inhibitor
iodoacetate (IAA) and blocker of oxidative phosphorylation
carbonylcyanide m-chlorophenylhydrazone (CCCP), by flow
cytometric analysis.
MATERIALS AND METHODS
Experimental cells 
Human astrocytoma cell line HTB-15 and CRL-1690 cells
were cultivated in T-tube flask. Dulbecco’s modified minimal
essential medium (DMEM) for HTB-15 cells and DMEM
with 1.5 g/L sodium bicarbonate, 1.0 mM sodium pyruvate
was used for CRL-1690 cells. The medium was supplement-
ed with 10% fetal calf serum and 100 IU penicillin G and
50  g/mL streptomycin. The cells were incubated in a 5%
CO2 chamber at a humidified atmosphere. Once the cells were
grown confluent to the flask, the cells were harvested for the
experiment with 0.1% trypsin-EDTA in a phosphate buffer
solution (PBS) and washed twice thereafter. The addition of
DMEM blocked the trypsin activity, and then suspension cells
were transferred to the other T-tube. For the flow cytometric
analysis, 2-3 mL of cell suspension were again transferred to
the cuvette. In order to control the metabolic rate of experi-
mental cells carefully, harvested cells only in the 3-5 passages
were used. 
Induction of cell damage and effect of ketamine
To mimic the ischemic damage in vitro, cells were treated
with IAA/CCCP 1.5 mM/20  M or 150  M/2  M for 1 hr.
And then, to observe reperfusion-induced cellular damage or
the effect of ketamine during the reperfusion, experimental
protocols called for cells to be exposed to normal media or
ketamine (0.1 mM or 0.5 mM)-containing media for 1 hr or
24 hr after wash out of agonists. Also, to investigate the effect
of ketamine itself on the PI binding, ketamine 0.1 mM or
0.5 mM was added to the perfusion media without ischemic
insult.
Measurement of cellular viability by Annexin-V and PI
binding 
For the measurement of surface exposure of PS and plasma
membrane leakage of experimental cells with flow cytometry
system, 105 cells were incubated with FITC-annexin-V (1  g/
mL) for 15 min and PI (2  g/mL) for 2 min in a dark area at
room temperature, and then washed with calcium-containing
phosphate buffered solution to remove excess fluorescent dyes.
We used commercially available FITC-annexin-V and PI (Tre-
vigen Inc, Gaithersburg, MD, U.S.A.), and those were dilut-
ed to 1:50, 1:10 with calcium buffer solution, respectively,
in this experiment. 
Flow cytometry
All experiments were performed using a FACStar Plus Flow
Cytometer (Becton Dickinson, Sunnyvale, CA, U.S.A.) equipp-
ed with a single argon ion laser exciting at 488 nm. FITC-
annexin-V fluorescence was collected through a 530 nm band
pass filter while PI fluorescence was measured through 639
nm band pass filter (19). It was designed specifically to detect
cellular changes of less than 1%. Prior to every experiment,
the flow cytometry was calibrated electrically and mechani-
cally by latex beads with already known diameter. Quanti-
tative analysis of cell viability of 104 cells was performed in
20 sec. The mean value of cellular changes was obtained by the
computer analysis of cytogram. The X, Y-axis indicated the
fluorescence of PI and annexin-V, respectively. By the gate of
the 4 areas, it was possible to detect and quantitatively com-
pare normal cells (annexin-V
-/PI
-), early apoptosis (annexin-
V
+/PI
-), late apoptosis or necrosis (annexin-V
+/PI
+) in the whole
cell population.
Alterations of cellular characteristics were also analyzed by
the degree and direction of light scattering through laser beam
of flow cytometry. FSC determines cell volume, SSC for cel-
lular granularity, density and folding. Decrease in FSC and
increase in SSC indicative of cell shrinkage and increased cell
granularity, respectively, indicate early phase of apoptosis. In-
crease in FSC and decrease in SSC are associated with late
phase of apoptosis. Therefore, flow cytometry was also utilized
to assess viable cells, early or late phase of apoptosis according
to cell volume and degree of cellular granularity. In order to
analyze better morphological changes with treatment, we
expressed cell volume and granularity as % of those of the
control cells without any treatment. 
Statistical analysis
Experimental data were expressed as mean±SD. To com-
pare between the two groups the unpaired t-test was perform-
ed. p value less than 0.05 was considered statistically signifi-
cant. Jandel Sigma Stat (version 2.0, Jandel Corporation, Chi-
cago, IL, U.S.A.) was used for statistical analysis.Effect of Ketamine on Apoptosis in Astroglioma Cells 115
RESULTS
The effect of ketamine on the annexin-V binding and PI
uptake during reperfusion for 1 hr
Annexin-V binding and PI uptake according to the con-
centrations of IAA/CCCP were observed in CRL-1690 cells.
The portion of annexin-V positive cells and PI positive cells
increased from 4.9% and 0.8% in control cells to 8.8% and
1.9% in cells treated with IAA/CCCP 150  M/2  M for 1 hr,
respectively (Fig. 1A). In a different condition, annexin-V pos-
itivity and PI positivity changed from 12.3% and 3.8% to
23.7% and 3.1%, respectively after treatment with IAA/
CCCP 1.5 mM/20  M (Fig. 1B). These results demonstrat-
ed the relationship between intracellular energy depletion
and PS redistribution.
The administration of ketamine 0.1 mM during the reper-
fusion induced an increase in the portion of vital cells (annex-
in-V and PI negative cells) from 90.6% to 93.6% (Fig. 2A),
and from 76.1% to 81.2%, respectively, after the insult with
IAA/CCCP 150  M/2  M, and 1.5 mM/20  M (Fig. 2B).
These showed that ketamine plays a potential role in the inhi-
bition of PS redistribution during intracellular energy deple-
tion. 
The effect of ketamine on the annexin-V binding and PI
uptake during reperfusion for 24 hr 
Only cellular debris was found following treatment with
a higher concentration of IAA/CCCP for 1 hr and reperfusion
for 24 hr. The experimental results after treatment with a low
concentration of IAA/CCCP, 150  M/2  M, for 1 hr and reper-
fusion for 24 hr exhibited similar patterns of responses as with
other experiments. The viable cells decreased from 91.7%
to 81.5% after reperfusion, but the administration of keta-
mine 0.1 mM during the reperfusion caused an increase in
Fig. 1. Bivariate PI/annexin-V analysis of the CRL-1690 cells during the reperfusion for 1 hr after IAA/CCCP treatment. Quadrant % gated
in this assay identify the different cell populations, i.e. region UL: PI-positive/ annexin-V-negative, UR: PI-positive/ annexin-V-positive, LL:
PI-negative/annexin-V-negative, LR: PI-negative/ annexin-V-positive. (A) and (B) indicate the effect of different concentrations of IAA/CCCP
(150  M/2  M vs. 1.5 mM/20  M) on the cell apoptosis. 
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Fig. 2. The effect of ketamine on the apoptosis of the CRL-1690 cells during the reperfusion for 1 hr Ketamine 0.1 mM addition during the
reperfusion increased cell viability after both low (A) and high concentration (B) IAA/CCCP treatment.
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LR 0.19 B Athe viable cells to 85.1% (Fig. 3A). In the other experiments
with a viability of 85.5%, reperfusion left only 19.9% of cells
viable. The addition of ketamine in this condition also saved
cell viability of up to 33.7% (Fig. 3B). Based on these results,
we found that the addition of ketamine during the reperfu-
sion protected cells from the progression of apoptosis in any
condition. 
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Fig. 3. Bivariate PI/annexin V analysis of the CRL-1690 cells during the reperfusion for 24 hr. A, B, C indicate cells in normal media for 24 hr,
in reperfusion for 24 hr after IAA/CCCP (150  M/2  M) treatment for 1 hr and in reperfusion with ketamine 0.1 mM containing media after
IAA/CCCP treatment, respectively. (A) and (B) are examples of many experiments.
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Fig. 4. The effect of ketamine on the changes of size and granularity of the HTB-15 cells. Forward light scattering properties measured the
size of cells in the normal media for 1 hr (1), in reperfusion for 1 hr after IAA/CCCP (150  M/2  M) treatment for 1 hr (2), and in reperfusion
with ketamine 0.1 mM containing media for 1 hr after IAA/CCCP treatment (3), respectively (A). Side light scattering properties measured
the granularity of cells (B) in the normal media for 1 hr (1), in reperfusion for 1 hr after IAA/CCCP (150  M/2  M) treatment for 1 hr (2), and
in reperfusion with ketamine 0.1 mM containing media for 1 hr after IAA/CCCP treatment (3).
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A B CThe effect of ketamine on cell volume and granularity
Fig. 4 clearly showed the effect of ketamine 0.1 mM on the
change of cellular volume and granularity following IAA/
CCCP (150  M/2  M) treatment in HTB-15 cells. The addi-
tion of ketamine during the reperfusion ameliorated the de-
crease in. Compared to the control condition, cell volume de-
creased to 71, 68, 68%, while cell granularity increased to 123,
131, 139%, respectively, during the reperfusion for 1 hr after
energy depletion in HTB-15 cells. These cellular changes were
indicative of apoptosis. An addition of ketamine 0.1 mM dur-
ing the reperfusion reduced cell shrinkage to 72, 69, 79%
of control cells and increased granularity to 113, 127, 132%
of control cells, respectively. CRL-1690 cells also showed sim-
ilar effect of ketamine on the cellular changes after energy
depletion (Table 1). 
During reperfusion for 24 hr after being exposed to IAA/
CCCP 150  M/2  M for 1 hr, however, both HTB-15 and
CRL-1690 cells showed cell swelling, rather than cell shrink-
age. This indicated morphological changes from the early
phase of apoptosis to late stage of apoptosis. The addition of
ketamine during the reperfusion protected cells from swelling.
However, the changes of cellular granularity was not consis-
tent, thereby, the effect of ketamine on the cellular granular-
ity after reperfusion for 24 hr was not observed (Table 2). 
The effect of ketamine on the membrane integrity 
This experiment was performed to investigate the effect of
ketamine on the PI binding during the reperfusion for 24 hr
following IAA/CCCP treatment in CRL-1690 cells. PI pos-
itive cells increased 7.4% in control cells to 80.8% in cells
treated with IAA/CCCP 150  M/2  M. The addition of ke-
tamine at both concentrations of 0.1 mM and 0.5 mM during
the reperfusion significantly decreased PI binding to 73.1%
and 65.2%, respectively. PI positive cells with ketamine 0.1
mM or 0.5 mM were 6.6% and 8.4%, respectively, which
showed no difference with the control data. Therefore, we
found that ketamine protected cells from increased plasma
membrane permeability due to energy depletion, rather than
affect normal cell membrane integrity (Table 3).
DISCUSSION
Ischemia-induced pathologic processes in the CNS are one
of the leading causes of primary mortality and morbidity. ATP
is required for a number of vital neuronal processes and energy
failure evokes numerous pathologic events including apoptosis.
Many previous studies reported that astrocyte function could
critically influence neuronal survival during ischemia. There-
fore, we mimicked ischemic condition in vitro by using IAA/
CCCP for depleting intracellular energy. In this study, we de-
monstrated the evidence of ketamine effect on the reduction of
apoptosis in astrocytoma cells by using flow cytometry system.
In this experiment, we used Annexin-V and PI as indica-
tors for apoptosis. Recently Yu et al. (20) demonstrated that
the mechanism of astroglial cell death due to ischemic insults
is apoptosis by using annexin-V staining. Annexin-V cannot
penetrate the double layer of cell membrane and interact with
PS. PS mostly faces the cytosol by outside-inside PS translo-
case, using ATP, in the normal cells. Having damages to the
cells including hypoxia or ischemia, internally located PS moves
over the outer leaflet of the plasma membrane; hence allow-
ing the binding of annexin-V (21).
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The cells were reperfused with normal media or ketamine 0.1 mM con-
taining media for 1 hr after IAA/CCCP (150  M/2  M) treatment for 1 hr.
Values are mean±SD. *p <0.05 compared with reperfusion with normal
media.
FSC (% of control)
Normal media
with ketamine
Normal
media 
FSC (% of control)
Normal media
with ketamine
Normal
media 
HTB-15 71±0.8 72±0.7 123±1.7 113±1.9*
68±0.8 69±0.9 131±1.2 127±1.0*
68±0.8 79±1.7* 139±0.5 132±0.9*
CRL-1690 91±1.2 95±0.3* 124±0.8 120±0.5*
87±1.8 90±1.1* 127±2.8 121±1.1*
Table 1. The esffect of ketamine on the changes of FSC and
SSC during reperfusion for 1 hr after IAA/CCCP treatment 
The cells were reperfused with normal media or ketamine 0.1 mM con-
taining media for 24 hr after IAA/CCCP (150  M/2  M) treatment for 1 hr.
Values are mean±SD. *p <0.05 compared with reperfusion with normal
media.
FSC (% of control)
Normal media
with ketamine
Normal
media 
FSC (% of control)
Normal media
with ketamine
Normal
media 
HTB-15 107±1.4 103±0.3* 122±2.7 129±0.6*
105±1.4 99±2.0* 106±1.1 103±1.0*
CRL-1690 124±2.7 108±2.5* 105±2.0 107±2.2
115±3.8 104±1.0* 82±2.2 79±2.3*
Table 2. The effect of ketamine on the changes of FSC and SSC
during reperfusion for 24 hr after IAA/CCCP treatment 
Values are mean±SD. *p <0.05 compared with control; 
� p <0.05 com-
pared with reperfusion after IAA/CCCP.
Treatment PI (%)
Control 7.4±0.5
Reperfusion after IAA/CCCP 80.8±2.5*
Reperfusion with ketamine 0.1 mM after IAA/CCCP 73.1±1.6
�
Reperfusion with ketamine 0.5 mM after IAA/CCCP 65.2±3.7
�
Ketamine 0.1 mM 6.6±0.6
Ketamine 0.5 mM 8.4±0.4
Table 3. The effect of ketamine on PI binding in the CRL-1690
cells during reperfusion for 24 hr after IAA/CCCP (150  M/2  M)
treatment for 1 hrAnnexin-V assay with flow cytometry for assessing apopto-
sis is simple and useful. The observation with electron micro-
scopic analysis to discriminate between apoptosis and necro-
sis is elaborate, time consuming, and cumbersome for quan-
titative analysis (5, 6). Although terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP-biotin nick-end labeling
(TUNEL) analysis shows a high level of specificity, experimen-
tal method is complicated and requires 3-4 hr to complete
(22). Flow cytometry using annexin-V fluorescence allows
rapid quantitative measurement in 5-10 min, and is relatively
easy because it does not require enzyme or fixation (23). In
addition, DNA fragmentation is not an early event in apop-
tosis, and not always associated with apoptosis. Apoptosis is
a programmed, physiologic mode of cell death, which is char-
acterized by structural nuclear changes, but also relatively by
preserved plasma membrane and organelle components. Re-
cently the externalization of PS has been demonstrated in the
absence of nuclear damage (24). This indicates that a cytoplas-
mic apoptotic regulator may be responsible for apoptosis in
the early phase. Castedo et al. (25) suggested that the redistri-
bution of PS was not affected by increased intracellular cal-
cium ion or reactive oxygen species (ROS), but disruption
of mitochondrial membrane potential. When lymphocytes
are exposed to CCCP, breakdown of mitochondrial potential
was demonstrated in a few minutes, followed by PS exposure
on the outer membrane layer in 60 min.
The addition of pharmacological agents which stabilize
mitochondrial membrane potential or inhibit disruption of
mitochondrial potential, protected PS exposure (26). There-
fore, aberrant PS movement may be a secondary effect sub-
sequent to the disruption of mitochondrial membrane poten-
tial. Moreover, the functional impact of mitochondrial respi-
ratory chain may be significant during the reperfusion period
than during the ischemic insult, by the rapid ionic movement
through the damaged membrane (27). Changes of mitochon-
drial membrane potential are irreversible and appear in sev-
eral cells in the early event of apoptosis, without exception.
Less than 5% of annexin-V positive cells contain normal nucle-
ar morphology. Loss of plasma membrane asymmetry by the
cell surface exposure of PS precedes loss of membrane integri-
ty, increased membrane permeability and nuclear condensa-
tion (3, 5, 24, 28).
Annexin-V is commonly used to analyze apoptotic cell death
in suspending cells. But, approximately 1-5% of cells in cul-
ture medium show apoptosis (5). Trypsinization to detach
adherent cells from the culture plate may cause membrane
damage by handling and following annexin-V staining. In
the human lung carcinoma cell line MR-65, approximately
25% of the suspension cells showed annexin-V binding and
a lack of PI uptake after trypsin treatment (5). About 10%
of control cells were positive for PI in PC-12 cell line (4). In
this experiment, the portion of the HTB-15 and CRL-1690
cells showing both annexin-V and PI negativity after trypsi-
nization ranged from 85 to 95%. Therefore these cells were
appropriate for performing experiment on the apoptotic process.
Apoptosis has been described to occur under several stim-
ulations. We found that in this experiment, the degree of re-
distribution of PS depended on the concentration of IAA/
CCCP: higher concentration of IAA/CCCP is associated with
increased annexin-V and PI uptake during the reperfusion
(Fig. 1). The addition of ketamine 0.1 mM during the reper-
fusion increased viable cells with both annexin-V and PI neg-
ative staining, compared to reperfusion without ketamine
(Fig. 2, 3). This finding strongly suggests that ketamine was
able to restore intracellular energy, maintain membrane integri-
ty by the inhibition of phospholipid membrane peroxidation,
consequently protect cells from PS redistribution and PI entry
intracellulary. Zhou et al. (29) suggested that the addition of
ketamine 0.1-10 mM inhibited chemical- or ischemia-induced
lipid peroxidation and ischemic glutathione depletion.
For mimicking energy depletion we used CCCP in this
experiment. As an uncoupler of mitochondrial respiratory
chain, CCCP decreases mitochondrial membrane potential,
causes alterations of energy metabolism, produces membrane
peroxidation and disrupt membrane integrity due to structural
and functional alterations (25, 26). Table 1, 2 represents the
results concerning the changes of cell volume and granularity
due to intracellular energy depletion, by using forward and
side light scattering on flow cytometry. Reperfusion for 1 hr
causes cell shrinkage and increased granularity, but in the late
apoptotic phase a progressive water influx causes cell swelling
and increased the release of intracellular organelles, which
can be related to decreased granularity. It is evident that the
progression of early apoptosis to secondary necrotic cell death
is dependent on the intensity of the stimulus and the energy
status of the cell (30, 31). CsA-induced apoptosis in the renal
proximal tubular cell line, LLC-PK1 showed increased FITC-
annexin-V affinity and cell granularity, and decreased cell
volume with a low dose, while decreased membrane integrity
and cell granularity, and increased cell volume in higher con-
centration (19). In the apoptosis of HL-60 cells induced by
UV exposure for 30 min, morphological change showing cel-
lular swelling, the phenomenon of secondary cellular necro-
sis, was observed after 6 hr under the electronic microscopy
(1). As time passes, the entry of PI was increased in fresh cells
without stimuli, although cell morphology was well preserved
under electronic microscopy (32).
We found that ketamine addition during the reperfusion
for 1 hr ameliorated morphological changes of apoptosis, such
as cellular shrinkage and increased cellular granularity (Table
1), and ketamine addition during the reperfusion for 24 hr also
ameliorated cellular necrosis accompanying cellular swelling
(Table 2). Chen and Simard (33) also demonstrated that hy-
poxia-ischemia and ATP depletion are associated with glial
swelling and blebbing. Ketamine 0.1 mM itself was found
not to induce apoptosis by the observation that annexin-V
affinity or PI uptake was not increased. Thus, ketamine was
effective in two types of cell death, both early stage of apop-
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As a non-competitive NMDA receptor blocker (34), keta-
mine produced considerable neuroprotection after mechani-
cal trauma or ischemic injury. Until very recently, NMDA
receptor was demonstrated only in the neuronal cell mem-
brane, however, Krebs et al. revealed the expression of func-
tional NMDA receptor in astrocytes under the ischemic in-
sults by immunohistochemistry (35). Ketamine may become
a valuable agent in restoring vulnerable astrocytes (36). The
potential neuroprotective effect of ketamine was proved at the
cellular level (9, 32). Many studies revealed that ketamine
stabilized neuronal and glial electrophysiological functions
by regulating Ca2+, Na+, K+ conductance, thus maintaining
intracellular ion homeostasis (32, 37-39). Administration of
ketamine before anoxic-hypoxic insults preserved neuronal
action potential in the hippocampus and protected cellular
energy status, maintaining two-thirds of ATP production (9,
10). Related to experiments mimicking ischemic insult or
head trauma in rats, ketamine improved neurological out-
comes by inhibiting pathophysiologic NO production as a
potential blocker for NMDA receptor (11, 32), decreasing
catecholamine level (12) and ameliorating brain swelling (8).
Using harvested cells, which have similar characteristics of
primary cells, is relatively easy in vitro experiment. We used
astroglioma cells instead of primary astrocytes in the current
study. Recently, the capacity of the CNS has been revealed
in many studies. As the most abundant cell type in the cen-
tral nervous system, astrocytes play very important and diverse
roles, interacting with neurons. Astrocytes provide structural,
trophic, and metabolic support to neurons and coordinate with
neurons in neurotransmission. A large body of studies has
demonstrated on the relationship between neurons and astro-
cytes survival. The addition of astrocyte-conditioned medium
in the serum free medium allows neurons to be attached to
the bottom of the coverslip and neuritis outgrowth, whereas
in the absence of astrocyte-conditioned medium impairment
of neuronal survival was shown (17). In the condition of co-
culture of neurons and astrocytes, removal of astrocytes caused
neuronal apoptosis (16). To prevent hypoxia-ischemia induced
neuronal degeneration, astrocytes survival is crucial (37).
In conclusion, we have demonstrated the occurrence of early
and late phase of apoptosis during the reperfusion after intra-
cellular energy depletion in astrocytoma cells by using flow
cytometry system. Ketamine addition during the reperfusion
protected astrocytoma cells from annexin-V binding and PI
uptake, and changes of cell volume and granularity. Consid-
ering the intimate functional and structural interaction of
astrocyte with neuron in the CNS, the presence of astrocyte
is very important for neuronal survival. 
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